{
  "report_rows": [
    {
      "kpi": "Q2 2026 underlying EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.55 vs. cons $1.52",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.07B vs. cons $3.086B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 U.S. financial volume growth",
      "prediction": "MISS",
      "answer": "pred ~-8.3% vs. cons -7.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Underlying EPS",
      "prediction": "LOWER",
      "answer": "guide ~$4.72 vs. cons $4.77 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Net sales",
      "prediction": "UNCHANGED",
      "answer": "guide ~$11.14B vs. cons $11.12B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Underlying free cash flow",
      "prediction": "BETTER",
      "answer": "guide ~$1.10B vs. cons $1.08B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.3,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Weak U.S. volume quality and an FY2026 EPS guide midpoint of ~$4.72 vs. consensus $4.77 should outweigh a modest Q2 EPS beat, prompting lower second-half and 2027 estimates after the call.",
  "day5_confidence": "MEDIUM"
}